A Study to Assess PK, Safety and Efficacy of HSK47977 Tablets in Subjects With Relapsed or Refractory Non-Hodgkin’s Lymphoma

by | Dec 19, 2025 | Clinical Trials | 0 comments

​ Conditions: NHL

Interventions: Drug: HSK47977

Sponsors: Haisco Pharmaceutical Group Co., Ltd.

Recruiting Conditions: NHL
Interventions: Drug: HSK47977
Sponsors: Haisco Pharmaceutical Group Co., Ltd.
Recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *